Home>Latest
- May 05, 2022
China sees new consumption trend in May Day holiday
Camping at neighboring areas became a top choice for many residents in China during the past Labor Day holiday from April 30 to May 4 as some parts of the country have been impacted by the COVID-19 pandemic, according to the data from online travel agencies including Ctrip and Fliggy, the Securities Daily reported on Thursday.
- May 05, 2022
Number of university graduates hits record high amid tight job market
The number of university graduates in China hit a record high of 10.76 million this year, increasing by 1.67 million, while the expected salaries fell from 6,711 yuan ($1,015.37) per month last year to 6,295 yuan, according to a latest report by Zhaopin, an online recruitment platform.
- May 05, 2022
Consumption tops 1b yuan in Ningbo during May Day holiday
The sales volume of 50 monitored businesses including shopping malls, supermarkets, car dealerships, hotels, and restaurants in Ningbo, East China's Zhejiang province hit 1.08 billion yuan ($166.3 million) during the five-day May Day holiday, which ended on May 4, official statistic show.
- April 29, 2022
Chinese shares soar on Friday
Chinese stocks surged on Friday, with the benchmark Shanghai Composite Index up 2.41 percent at 3,047.06 points.
- April 29, 2022
Expert says China's dynamic zero-COVID policy can defeat the epidemic
China can defeat the COVID-19 epidemic by seizing the window of opportunity created by its dynamic clearance strategy to accelerate vaccination, ramp up emergency response capacity and expand the use of effective medications, a senior health expert said on Friday.
- April 29, 2022
Transport regulators easing logistics operations
China's transport regulators have bolstered steps to resume the smooth flow of logistics across the country, providing sufficient supplies for people and enterprises to areas hit by the novel coronavirus, officials said on Thursday.
- April 29, 2022
Vaccines against Omicron approved for clinical trials
Two homegrown Omicron-specific COVID-19 vaccine candidates developed by Sinopharm and Sinovac Biotech have been approved for clinical trials by China's top drug regulator, the two companies said on Tuesday.
- April 29, 2022
Digital yuan trial gains traction in Ningbo
A total of 317,000 digital yuan wallets had been opened in Ningbo, East China's Zhejiang province as of April 26.
